369
Participants
Start Date
January 28, 2015
Primary Completion Date
January 20, 2016
Study Completion Date
December 29, 2020
Sarilumab
Pharmaceutical form: solution for injection in pre-filled syringe; Route of administration: SC
Adalimumab
Pharmaceutical form: solution for injection in pre-filled syringe; Route of administration: SC
Placebo (for sarilumab)
Pharmaceutical form: solution for injection in pre-filled syringe; Route of administration: SC
Placebo (for adalimumab)
Pharmaceutical form: solution for injection in pre-filled syringe; Route of administration: SC
Investigational Site Number 348025, Budapest
Investigational Site Number 348020, Budapest
Investigational Site Number 348022, Budapest
Investigational Site Number 710004, Kempton Park
Investigational Site Number 710011, Cape Town
Investigational Site Number 710007, Cape Town
Investigational Site Number 348023, Veszprém
Investigational Site Number 348024, Szombathely
Investigational Site Number 203001, Prague
Investigational Site Number 203033, Prague
Investigational Site Number 724012, Santiago de Compostela
Investigational Site Number 840130, Lewes
Investigational Site Number 804011, Vinnitsya
Investigational Site Number 804043, Vinnitsya
Investigational Site Number 840073, Cumberland
Investigational Site Number 840202, Hagerstown
Investigational Site Number 840402, Charlotte
Investigational Site Number 840406, Hickory
Investigational Site Number 724001, Málaga
Investigational Site Number 840128, Ormond Beach
Investigational Site Number 840229, Coral Gables
Investigational Site Number 840140, Tampa
Investigational Site Number 840403, St. Petersburg
Investigational Site Number 376031, Haifa
Investigational Site Number 410004, Daejeon
Investigational Site Number 804049, Poltava
Investigational Site Number 724007, Seville
Investigational Site Number 410005, Daegu
Investigational Site Number 804037, Lutsk
Investigational Site Number 840404, Middleburg Heights
Investigational Site Number 840232, Flint
Investigational Site Number 724003, Barakaldo
Investigational Site Number 276021, Osnabrück
Investigational Site Number 276058, Cologne
Investigational Site Number 376030, Ramat Gan
Investigational Site Number 804048, Kharkiv
Investigational Site Number 376011, Tel Aviv
Investigational Site Number 840112, Lincoln
Investigational Site Number 840127, Oklahoma City
Investigational Site Number 840074, Mesquite
Investigational Site Number 804029, Ivano-Frankivsk
Investigational Site Number 376032, Ashkelon
Investigational Site Number 804046, Lviv
Investigational Site Number 840141, Whittier
Investigational Site Number 840400, Long Beach
Investigational Site Number 840407, Covina
Investigational Site Number 643020, Moscow
Investigational Site Number 643001, Moscow
Investigational Site Number 643031, Moscow
Investigational Site Number 643030, Moscow
Investigational Site Number 643008, Saint Petersburg
Investigational Site Number 643011, Saratov
Investigational Site Number 643006, Kemerovo
Investigational Site Number 642005, Galati
Investigational Site Number 642006, Brăila
Investigational Site Number 152015, Temuco IX Region
Investigational Site Number 152005, Osorno
Investigational Site Number 152002, Santiago
Investigational Site Number 152050, Santiago
Investigational Site Number 152001, Puerto Varas
Investigational Site Number 152014, Talca
Investigational Site Number 152007, Viña del Mar
Investigational Site Number 203030, Prague
Investigational Site Number 616015, Elblag
Investigational Site Number 203002, Uherské Hradiště
Investigational Site Number 604003, Lima
Investigational Site Number 604005, Lima
Investigational Site Number 604022, Lima
Investigational Site Number 616056, Bytom
Investigational Site Number 616005, Lublin
Investigational Site Number 616030, Lublin
Investigational Site Number 616055, Nadarzyn
Investigational Site Number 616018, Poznan
Investigational Site Number 616016, Szczecin
Investigational Site Number 616004, Warsaw
Investigational Site Number 616031, Warsaw
Investigational Site Number 642001, Bucharest
Investigational Site Number 642010, Bucharest
Investigational Site Number 642002, Bucharest
Investigational Site Number 410006, Seoul
Investigational Site Number 410001, Seoul
Investigational Site Number 724015, Barcelona
Investigational Site Number 724011, Barcelona / Sabadell
Investigational Site Number 804014, Kyiv
Investigational Site Number 804047, Kyiv
Investigational Site Number 826001, Leytonstone
Lead Sponsor
Regeneron Pharmaceuticals
INDUSTRY
Sanofi
INDUSTRY